October 5, 2018 — The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27…Original Article
FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 Through 45 Years Old
